Search for: "State v. Bartlett"
Results 1 - 20
of 494
Sorted by Relevance
|
Sort by Date
17 May 2011, 2:05 am
Bartlett and others v Secretary of State for Work and Pensions Case (C-537/09); [2011] WLR (D) 158 “The mobility component of disability living allowance constituted a special non-contributory benefit within the meaning of article 4(2a) of and Annex IIa to Council Regulation (EEC) No 1408/71 as amended by Council Regulation (EC) No 118/97 and Parliament and Council Regulation (EC) No 631/2005, and of Council Regulation (EEC) No 1408/71 as amended by Parliament and… [read post]
27 Jul 2013, 5:00 am
The subject is preemption – specifically the the United States Supreme Court’s recent ruling in Mutual Pharmaceutical Company, Inc. v. [read post]
27 Dec 2012, 3:47 pm
Bartlett v. [read post]
24 Jun 2013, 12:50 pm
In Bartlett v. [read post]
19 Mar 2013, 6:58 am
Bartlett – that is to say Mutual Pharmacy Co. v. [read post]
2 May 2012, 1:27 pm
The First Circuit decided Bartlett v. v. [read post]
29 May 2012, 9:48 am
We previously wrote about the First Circuit's decision in Bartlett v. [read post]
8 Oct 2013, 3:53 pm
Bartlett. [read post]
8 Oct 2013, 3:53 pm
Bartlett. [read post]
2 Jun 2015, 9:53 am
Here: State of Nebraska v Parker cert petition Questions presented: In Solem v. [read post]
9 Mar 2009, 9:17 am
The Supreme Court has decided Bartlett v. [read post]
23 Jul 2010, 7:28 am
Last Friday we had a brief post about the new decision in Bartlett v. [read post]
20 Aug 2010, 9:50 am
Bartlett v. [read post]
30 Nov 2012, 2:00 pm
Bartlett, that a state court plaintiff can argue that an FDA approved drug should be removed from the market altogether. [read post]
3 Jul 2013, 5:00 am
” Palmer v. [read post]
25 Jan 2013, 12:47 pm
We’ve received the same bone-headed response from an appellate court in a branded case, seeWimbush v. [read post]
13 Oct 2008, 1:59 pm
The Court will explore in Bartlett v. [read post]
7 May 2012, 5:00 am
Our initial post about Bartlett v. [read post]
4 Oct 2010, 1:07 pm
" Bartlett v. [read post]
24 Jun 2013, 8:30 pm
Bartlett that the Federal Food, Drug, and Cosmetic Act, or FDCA, preempted a state-law design-defect claim against a generic drug manufacturer. [read post]
